BCL2L1 and malignant colon neoplasm: The discovery that BAX-incompetent, unprimed TIS phenotypes in LoVo colon cancer cells retain sensitivity to the BCL-xL-specific BH3 mimetic A1331852 extends our current paradigm of senescence-associated vulnerabilities based on BH3 profiling.